It can therefore be hypothesized that PLA2 provides an effective treatment for inflammatory autoimmune diseases such as RA despite its known allergenic properties, mediated by the conversion of naïve CD4+ T cell into Foxp3+ Tregs. The gene discussed is PLA2G2A; the disease is rheumatoid arthritis.